The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Next-generation analytics in viral vector manufacturing
Webinar On Demand
Viral vectors that are used in gene therapies and gene-modified cell therapies face complex analytical challenges, requiring indirect and direct measurement methods and high-quality reagents. That’s why it’s crucial to develop standardized and validated analytical methods, reference standards, and reagents to ensure viral vector analysis accuracy, reproducibility, and comparability across applications. By addressing these analytical challenges, next-generation analytics can accelerate the development and translation of safe and effective viral vector-based gene therapies for patients.
Watch Thermo Fisher Scientific’s on-demand webinar, “Next-generation analytics in viral vector manufacturing” to learn:
- The roles for analytics in the production of viral vectors for gene therapies and gene-modified cell therapies
- Current challenges related to traditional analytical methods for determining viral vector quality and characterization
- Case studies showing how the next generation is addressing challenges in adeno-associated viruses and lentiviruses
- Challenges and considerations associated with new technology adoption and the future of viral vector analytics